Literature DB >> 21512421

Outcomes and special considerations of cochlear implantation in waardenburg syndrome.

Georgios Kontorinis1, Thomas Lenarz, Alexandros Giourgas, Martin Durisin, Anke Lesinski-Schiedat.   

Abstract

OBJECTIVES: The objective of this study was a state-of-the-art analysis of cochlear implantation in patients with Waardenburg syndrome (WS). PATIENTS: Twenty-five patients with WS treated with cochlear implants in our department from 1990 to 2010.
INTERVENTIONS: The 25 patients with WS underwent 35 cochlear implantations. MAIN OUTCOME MEASURES: Hearing outcome was evaluated using HSM sentence test in 65 dB in quiet, Freiburg Monosyllabic Test, and categories of auditory performance for children and compared with that of a control group. Anatomic abnormalities of the inner ear were examined using magnetic resonance imaging and computed tomography of the temporal bones.
RESULTS: The mean follow-up time was 8.3 years (range, 0.3-18.3 yr). The majority achieved favorable postimplantation performance with mean HSM scores of 75.3% (range, 22.6%-99%) and Freiburg Monosyllabic Test scores of 67.8% (range, 14%-95%). However, in 4 cases, the results were less satisfactory. The comparison with the control group did not reveal any statistical significance (p = 0.56). In 6 patients (24%), behavioral disorders caused temporary difficulties during the rehabilitation procedure. Except of isolated large vestibule in 1 patient, the radiological assessment of the 50 temporal bones did not reveal any temporal bone abnormalities.
CONCLUSION: Most patients with WS performed well with cochlear implants. However, WS is related to behavioral disorders that may cause temporary rehabilitation difficulties. Finally, temporal bone malformations that could affect cochlear implantation are notcharacteristic of WS.

Entities:  

Mesh:

Year:  2011        PMID: 21512421     DOI: 10.1097/MAO.0b013e31821b3ae3

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  7 in total

1.  Paediatric Cochlear Implantation in Patients with Waardenburg Syndrome.

Authors:  Josephine W I van Nierop; Rebecca R Snabel; Margreet Langereis; Ronald J E Pennings; Ronald J C Admiraal; Emmanuel A M Mylanus; Henricus P M Kunst
Journal:  Audiol Neurootol       Date:  2016-06-01       Impact factor: 1.854

2.  Cochlear implantation outcomes in children with Waardenburg syndrome.

Authors:  Susan Amirsalari; Mohammad Ajallouyean; Amin Saburi; Adel Haddadi Fard; Maryam Abed; Yasaman Ghazavi
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-11       Impact factor: 2.503

3.  Clinical and genetic investigation of families with type II Waardenburg syndrome.

Authors:  Yong Chen; Fuwei Yang; Hexin Zheng; Jianda Zhou; Ganghua Zhu; Peng Hu; Weijing Wu
Journal:  Mol Med Rep       Date:  2016-01-13       Impact factor: 2.952

4.  A novel mutation of the PAX3 gene in a Chinese family with Waardenburg syndrome type I.

Authors:  Jing Ma; Ken Lin; Hong-Chao Jiang; Yanli Yang; Yu Zhang; Guilian Yang; Hao Sun; Cheng Ming; Xianyun Bi; Tiesong Zhang; Biao Ruan
Journal:  Mol Genet Genomic Med       Date:  2019-06-12       Impact factor: 2.183

5.  The Hearing Outcomes of Cochlear Implantation in Waardenburg Syndrome.

Authors:  Hajime Koyama; Akinori Kashio; Aki Sakata; Katsuhiro Tsutsumiuchi; Yu Matsumoto; Shotaro Karino; Akinobu Kakigi; Shinichi Iwasaki; Tatsuya Yamasoba
Journal:  Biomed Res Int       Date:  2016-06-08       Impact factor: 3.411

6.  Cochlear morphology in the developing inner ear of the porcine model of spontaneous deafness.

Authors:  Wei Chen; Qing-Qing Hao; Li-Li Ren; Wei Ren; Hui-Sang Lin; Wei-Wei Guo; Shi-Ming Yang
Journal:  BMC Neurosci       Date:  2018-05-02       Impact factor: 3.288

Review 7.  Outcomes and benefits of pediatric cochlear implantation in children with additional disabilities: a review and report of family influences on outcomes.

Authors:  Ivette Cejas; Michael F Hoffman; Alexandra L Quittner
Journal:  Pediatric Health Med Ther       Date:  2015-05-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.